Cardvedilol Post Infarct Survival Control in Left Ventricular Dysfunction
Initiatives
-
We investigated the long-term efficacy of carvedilol on morbidity and mortality in patients with left-ventricular dysfunction after acute myocardial infarction treated according to current evidence-based practice.
*Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Clinical trial
- Follow Up
- Patients were followed up until the requisite number of primary endpoints had occurred
Marker Paper
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001 May 5;357(9266):1385-90. doi: 10.1016/s0140-6736(00)04560-8.
PUBMED 11356434
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 1,959
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |